FDA updates safety labels for Pfizer's Abrysvo and GSK's Arexvy RSV vaccines, citing increased Guillain-Barré syndrome risk.

Pfizer (PFE) reachead $26.91 at the closing of the latest trading day, reflecting a -0.83% change compared to its last close.

Pfizer ’s executive team was using Mar-a-Lago for a planning meeting over several days, the people said. While there was no scheduled meeting between Bourla and Trump, the pair were likely to interact ...

For patients with psoriatic arthritis, switching directly from adalimumab to tofacitinib with no washout period presents no ...

The final four dividend stocks to buy and hold in 2025 are a mixed assortment. The common denominators between these stocks ...

A statewide grand jury didn’t find evidence that COVID-19 vaccine manufacturers broke federal or state laws when making and ...

Green, a former pharmacist and pharma ad copywriter whose resume includes such agencies as Grey Healthcare and KPR (since ...

Among the FDA’s pending decisions for this quarter are Vertex’s non-opioid pain drug and Sanofi’s RNA interference therapy ...

However, the grand jury refused to bring any criminal indictments, finishing its 144-page final report on Nov. 22.

With a state grand jury report released Wednesday, Florida Gov. Ron DeSantis doubled down on the message he delivered often ...

A Canadian teen's breasts grew fourfold after receiving the Pfizer COVID-19 vaccine, raising concerns about a rare condition ...

Largecap, Midcap Shares To Buy: Axis Direct recommends buying Bajaj Finance, two other stocks for 2 weeks; note down targets Stocks To Buy For 2 Weeks: Brokerage recommends buying two stocks for ...